PortfoliosLab logoPortfoliosLab logo
IDNA vs. SOXX
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

IDNA vs. SOXX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA) and iShares Semiconductor ETF (SOXX). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, IDNA achieves a 9.51% return, which is significantly lower than SOXX's 101.03% return.


IDNA

1D
-2.18%
1M
-2.18%
YTD
9.51%
6M
10.53%
1Y
41.74%
3Y*
6.48%
5Y*
-8.26%
10Y*

SOXX

1D
5.79%
1M
29.90%
YTD
101.03%
6M
100.20%
1Y
192.69%
3Y*
56.47%
5Y*
34.67%
10Y*
35.56%
*Multi-year figures are annualized to reflect compound growth (CAGR)

IDNA vs. SOXX - Yearly Performance Comparison


2026 (YTD)2025202420232022202120202019
IDNA
iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund
9.51%17.26%-0.72%-7.63%-42.28%-3.98%54.30%20.83%
SOXX
iShares Semiconductor ETF
101.03%40.74%12.92%67.12%-35.09%44.09%52.72%33.94%

Correlation

The correlation between IDNA and SOXX is 0.41, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.41

Correlation (3Y)
Calculated over the trailing 3-year period

0.43

Correlation (5Y)
Calculated over the trailing 5-year period

0.50

Correlation (All Time)
Calculated using the full available price history since Jun 14, 2019

0.52

The correlation between IDNA and SOXX shifts across timeframes, from 0.41 (1 year) to 0.52 (all time), reflecting how their relationship changes across market environments.

IDNA vs. SOXX - Sectors Allocation Comparison


Sectors
IDNA
SOXX

Healthcare

97.8%

-

Industrials

0.4%

-

Basic Materials

-

-

Communication Services

-

-

Consumer Cyclical

-

-

Consumer Defensive

-

-

Energy

-

-

Financial Services

-

-

Real Estate

-

-

Technology

-

100.0%

Utilities

-

-

Healthcare

IDNA
97.8%
SOXX

-

Industrials

IDNA
0.4%
SOXX

-

Basic Materials

IDNA

-

SOXX

-

Communication Services

IDNA

-

SOXX

-

Consumer Cyclical

IDNA

-

SOXX

-

Consumer Defensive

IDNA

-

SOXX

-

Energy

IDNA

-

SOXX

-

Financial Services

IDNA

-

SOXX

-

Real Estate

IDNA

-

SOXX

-

Technology

IDNA

-

SOXX
100.0%

Utilities

IDNA

-

SOXX

-

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

IDNA vs. SOXX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

IDNA
IDNA Risk / Return Rank: 5757
Overall Rank
IDNA Sharpe Ratio Rank: 4949
Sharpe Ratio Rank
IDNA Sortino Ratio Rank: 5050
Sortino Ratio Rank
IDNA Omega Ratio Rank: 4343
Omega Ratio Rank
IDNA Calmar Ratio Rank: 7979
Calmar Ratio Rank
IDNA Martin Ratio Rank: 6464
Martin Ratio Rank

SOXX
SOXX Risk / Return Rank: 9797
Overall Rank
SOXX Sharpe Ratio Rank: 9898
Sharpe Ratio Rank
SOXX Sortino Ratio Rank: 9595
Sortino Ratio Rank
SOXX Omega Ratio Rank: 9595
Omega Ratio Rank
SOXX Calmar Ratio Rank: 9898
Calmar Ratio Rank
SOXX Martin Ratio Rank: 9797
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

IDNA vs. SOXX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA) and iShares Semiconductor ETF (SOXX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


IDNASOXXDifference

Sharpe ratio

Return per unit of total volatility

1.71

5.68

-3.97

Sortino ratio

Return per unit of downside risk

2.48

5.40

-2.92

Omega ratio

Gain probability vs. loss probability

1.28

1.75

-0.47

Calmar ratio

Return relative to maximum drawdown

4.09

12.50

-8.41

Martin ratio

Return relative to average drawdown

11.79

47.94

-36.15

IDNA vs. SOXX - Sharpe Ratio Comparison

The current IDNA Sharpe Ratio is 1.71, which is lower than the SOXX Sharpe Ratio of 5.68. The chart below compares the historical Sharpe Ratios of IDNA and SOXX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


IDNASOXXDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.71

5.68

-3.97

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.29

0.97

-1.26

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

1.07

Sharpe Ratio (All Time)

Calculated using the full available price history

0.10

0.45

-0.35

Drawdowns

IDNA vs. SOXX - Drawdown Comparison

The maximum IDNA drawdown since its inception was -68.26%, roughly equal to the maximum SOXX drawdown of -70.21%. Use the drawdown chart below to compare losses from any high point for IDNA and SOXX.


Loading charts...

Drawdown Indicators


IDNASOXXDifference

Max Drawdown

Largest peak-to-trough decline

-68.26%

-70.21%

+1.95%

Max Drawdown (1Y)

Largest decline over 1 year

-10.66%

-15.77%

+5.11%

Max Drawdown (3Y)

Largest decline over 3 years

-29.73%

-41.36%

+11.63%

Max Drawdown (5Y)

Largest decline over 5 years

-68.26%

-45.75%

-22.51%

Max Drawdown (10Y)

Largest decline over 10 years

-45.75%

Current Drawdown

Current decline from peak

-46.01%

0.00%

-46.01%

Average Drawdown

Average peak-to-trough decline

-36.24%

-19.97%

-16.27%

Ulcer Index

Depth and duration of drawdowns from previous peaks

3.70%

4.11%

-0.41%

Volatility

IDNA vs. SOXX - Volatility Comparison

The current volatility for iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA) is 7.24%, while iShares Semiconductor ETF (SOXX) has a volatility of 14.19%. This indicates that IDNA experiences smaller price fluctuations and is considered to be less risky than SOXX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


IDNASOXXDifference

Volatility (1M)

Calculated over the trailing 1-month period

7.24%

14.19%

-6.95%

Volatility (6M)

Calculated over the trailing 6-month period

18.21%

27.33%

-9.12%

Volatility (1Y)

Calculated over the trailing 1-year period

24.51%

34.17%

-9.66%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

28.42%

36.11%

-7.69%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

29.53%

33.43%

-3.90%

IDNA vs. SOXX - Expense Ratio Comparison

IDNA has a 0.47% expense ratio, which is higher than SOXX's 0.34% expense ratio.


Dividends

IDNA vs. SOXX - Dividend Comparison

IDNA's dividend yield for the trailing twelve months is around 1.08%, more than SOXX's 0.28% yield.


PositionTTM20252024202320222021202020192018201720162015
IDNA
iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund
1.08%1.18%0.98%1.04%0.54%0.70%0.26%0.80%0.00%0.00%0.00%0.00%
SOXX
iShares Semiconductor ETF
0.28%0.57%0.67%0.78%1.26%0.64%0.81%1.23%1.37%0.90%1.08%1.29%

Frequently Asked Questions


IDNA and SOXX have a correlation of 0.41, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

SOXX has higher volatility (14.19%) compared to IDNA (7.24%). In terms of maximum drawdown, IDNA dropped -68.26% vs SOXX's -70.21%.

On 5-year performance, SOXX leads with 34.67% vs -8.26% for IDNA. On fees, SOXX is cheaper at 0.34% per year. On volatility, IDNA has been the lower-risk option at 7.24%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 5-year period, SOXX has performed better with a 34.67% return vs -8.26%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

SOXX is cheaper with a 0.34% expense ratio, compared with 0.47% for IDNA.

IDNA has the higher dividend yield at 1.08%, compared with 0.28% for SOXX.

IDNA is categorized as Health & Biotech Equities, while SOXX is Semiconductors. IDNA tracks NYSE FactSet Global Genomics and Immuno Biopharma Index, while SOXX tracks NYSE Semiconductor Index. Their fees differ too: 0.47% for IDNA and 0.34% for SOXX.

SOXX currently has the higher Sharpe Ratio (5.68 vs 1.71), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for IDNA and SOXX

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer